Want to see HK:2196 full AI Analyst Report?
Shanghai Fosun Pharmaceutical (Group) Co (2196) Income Statement
5 Followers
Shanghai Fosun Pharmaceutical (Group) Co Income Statement
Last quarter (Q3 2026), Shanghai Fosun Pharmaceutical (Group) Co's total revenue was ¥10.02B, an increase of 1.44% from the same quarter last year. In Q3, Shanghai Fosun Pharmaceutical (Group) Co's net income was ¥946.02M. See Shanghai Fosun Pharmaceutical (Group) Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 40.42B | ¥ 41.07B | ¥ 41.40B | ¥ 43.95B | ¥ 39.01B | |
| ¥ 20.16B | ¥ 19.70B | ¥ 19.68B | ¥ 20.78B | ¥ 18.78B | |
| ¥ 17.63B | ¥ 15.46B | ¥ 16.50B | ¥ 17.15B | ¥ 16.06B | |
| Depreciation and Amortization | ¥ 3.51B | ¥ 3.00B | ¥ 2.97B | ¥ 2.34B | ¥ 1.83B |
| ¥ 6.05B | ¥ 8.60B | ¥ 7.55B | ¥ 7.87B | ¥ 8.70B | |
| ¥ 2.54B | ¥ 4.25B | ¥ 3.31B | ¥ 8.30B | ¥ 6.31B | |
| ¥ 2.44B | ¥ -75.82M | ¥ -42.94M | ¥ -82.27M | ¥ -259.90M | |
| ¥ 4.98B | ¥ 4.17B | ¥ 3.26B | ¥ 4.57B | ¥ 6.05B | |
| ¥ 3.28B | ¥ 2.77B | ¥ 2.39B | ¥ 3.73B | ¥ 4.73B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 1.24 | ¥ 1.04 | ¥ 0.89 | ¥ 1.43 | ¥ 1.85 |
| Diluted EPS | ¥ 1.24 | ¥ 1.04 | ¥ 0.89 | ¥ 1.43 | ¥ 1.85 |
| Weighted Average Shares Outstanding | 2.65B | 2.67B | 2.67B | 2.61B | 2.56B |
| Weighted Average Shares Outstanding (Diluted) | 2.65B | 2.67B | 2.67B | 2.61B | 2.56B |
Currency in CNY
